Diabetes Obesity & Metabolism

Journal Title：Diabetes Obesity & Metabolism

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

《糖尿病、肥胖和代谢》主要刊登临床和实验药理学和治疗学杂志，涵盖糖尿病、肥胖和代谢相关领域。该杂志优先刊登高质量的原创研究，报告新疗法或现有疗法（包括饮食、运动和生活方式（非药物）干预）对人类或动物和细胞系统代谢和内分泌疾病任何方面的影响。“代谢”可能与脂质、骨骼和药物代谢或内分泌功能障碍的更广泛方面有关。临床前药理学、药代动力学研究、荟萃分析以及涉及药物安全性和耐受性的研究也非常适合在该杂志上发表。原创研究可以作为主要论文或研究信函发表。

Diabetes Obesity & Metabolism创刊于1999年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵盖医学 - 内分泌学与代谢全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 一般,3-8周 ，影响因子指数5.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。